Topics

Study shows SGLT2 inhibitors' renoprotective effect in diabetes

06:35 EDT 11 Oct 2019 | SmartBrief

A study of 38,723 people with type 2 diabetes found the SGLT2 inhibitors canagliflozin, dapagliflozin and empagliflozin were  -More

Original Article: Study shows SGLT2 inhibitors' renoprotective effect in diabetes

NEXT ARTICLE

More From BioPortfolio on "Study shows SGLT2 inhibitors' renoprotective effect in diabetes"

Quick Search